Literature DB >> 20515694

The role of MeCP2 in CNS development and function.

Elisa S Na1, Lisa M Monteggia.   

Abstract

Rett syndrome is a neurodevelopmental disorder that is a direct consequence of functional mutations in the methyl-CpG-binding protein-2 (MeCP2) gene, which has focused attention on epigenetic mechanisms in neurons. MeCP2 is widely believed to be a transcriptional repressor although it may have additional functions in the CNS. Genetic mouse models that compromise MeCP2 function demonstrate that homeostatic regulation of MeCP2 is necessary for normal CNS functioning. Recent work has also demonstrated that MeCP2 plays an important role in mediating synaptic transmission in the CNS in particular, spontaneous neurotransmission and short-term synaptic plasticity. This review will discuss the role of MeCP2 in CNS development and function, as well as a potential important role for MeCP2 and epigenetic processes involved in mediating transcriptional repression in Rett syndrome.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515694      PMCID: PMC3077534          DOI: 10.1016/j.yhbeh.2010.05.014

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  66 in total

1.  Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice.

Authors:  M A Kurt; D C Davies; M Kidd; M Dierssen; J Flórez
Journal:  Brain Res       Date:  2000-03-06       Impact factor: 3.252

2.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.

Authors:  R Z Chen; S Akbarian; M Tudor; R Jaenisch
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

3.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

4.  Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes.

Authors:  R E Amir; I B Van den Veyver; R Schultz; D M Malicki; C Q Tran; E J Dahle; A Philippi; L Timar; A K Percy; K J Motil; O Lichtarge; E O Smith; D G Glaze; H Y Zoghbi
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

5.  Two affected boys in a Rett syndrome family: clinical and molecular findings.

Authors:  L Villard; A Kpebe; C Cardoso; P J Chelly; P M Tardieu; M Fontes
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

6.  Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein.

Authors:  P Watson; G Black; S Ramsden; M Barrow; M Super; B Kerr; J Clayton-Smith
Journal:  J Med Genet       Date:  2001-04       Impact factor: 6.318

Review 7.  Neuroimaging studies of normal brain development and their relevance for understanding childhood neuropsychiatric disorders.

Authors:  Rachel Marsh; Andrew J Gerber; Bradley S Peterson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-11       Impact factor: 8.829

8.  Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons.

Authors:  Richard D Smrt; Julialea Eaves-Egenes; Basam Z Barkho; Nicholas J Santistevan; Chunmei Zhao; James B Aimone; Fred H Gage; Xinyu Zhao
Journal:  Neurobiol Dis       Date:  2007-04-27       Impact factor: 5.996

9.  Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.

Authors:  Mari Kondo; Laura J Gray; Gregory J Pelka; John Christodoulou; Patrick P L Tam; Anthony J Hannan
Journal:  Eur J Neurosci       Date:  2008-06-14       Impact factor: 3.386

10.  Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.

Authors:  ChaRandle Jordan; Hong Hua Li; Helen C Kwan; Uta Francke
Journal:  BMC Med Genet       Date:  2007-06-20       Impact factor: 2.103

View more
  23 in total

1.  Methyl CpG Binding Protein 2 Gene Disruption Augments Tonic Currents of γ-Aminobutyric Acid Receptors in Locus Coeruleus Neurons: IMPACT ON NEURONAL EXCITABILITY AND BREATHING.

Authors:  Weiwei Zhong; Ningren Cui; Xin Jin; Max F Oginsky; Yang Wu; Shuang Zhang; Brian Bondy; Christopher M Johnson; Chun Jiang
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

Review 2.  MicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites.

Authors:  Silvia Bicker; Martin Lackinger; Kerstin Weiß; Gerhard Schratt
Journal:  Cell Mol Life Sci       Date:  2014-07-10       Impact factor: 9.261

3.  Neonatal MeCP2 is important for the organization of sex differences in vasopressin expression.

Authors:  Robin M Forbes-Lorman; Jared J Rautio; Joseph R Kurian; Anthony P Auger; Catherine J Auger
Journal:  Epigenetics       Date:  2012-03       Impact factor: 4.528

4.  Up-regulated methyl CpG binding protein-2 in intractable temporal lobe epilepsy patients and a rat model.

Authors:  Shuxin Tao; Xiaolan Yang; Yangmei Chen; Xuefeng Wang; Zhanqin Xiao; Heng Wang; Qisi Wu; Xing Wang
Journal:  Neurochem Res       Date:  2012-06-17       Impact factor: 3.996

5.  Enhancement of postsynaptic GABAA and extrasynaptic NMDA receptor-mediated responses in the barrel cortex of Mecp2-null mice.

Authors:  Fu-Sun Lo; Mary E Blue; Reha S Erzurumlu
Journal:  J Neurophysiol       Date:  2015-12-16       Impact factor: 2.714

6.  Expression of Phospho-MeCP2s in the Developing Rat Brain and Function of Postnatal MeCP2 in Cerebellar Neural Cell Development.

Authors:  Fang Liu; Jing-Jing Ni; Feng-Yan Sun
Journal:  Neurosci Bull       Date:  2016-12-19       Impact factor: 5.203

Review 7.  The impact of MeCP2 loss- or gain-of-function on synaptic plasticity.

Authors:  Elisa S Na; Erika D Nelson; Ege T Kavalali; Lisa M Monteggia
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

Review 8.  Drosophila modeling of heritable neurodevelopmental disorders.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Curr Opin Neurobiol       Date:  2011-05-17       Impact factor: 6.627

9.  Genotyping FOXG1 Mutations in Patients with Clinical Evidence of the FOXG1 Syndrome.

Authors:  D W Pratt; J V Warner; M G Williams
Journal:  Mol Syndromol       Date:  2012-12-12

Review 10.  Epigenetic layers and players underlying neurodevelopment.

Authors:  Janine M LaSalle; Weston T Powell; Dag H Yasui
Journal:  Trends Neurosci       Date:  2013-05-31       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.